CRYO-CELL INTL INC (CCEL) Stock Overview
USA - NYSEARCA:CCEL - US2288951088 - Common Stock
CCEL Key Statistics, Chart & Performance
The current stock price of CCEL is 4.4 USD. In the past month the price increased by 9.98%. In the past year, price decreased by -28.93%.
CCEL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.56 | 92.96B | ||
| CI | THE CIGNA GROUP | 10.59 | 79.42B | ||
| LH | LABCORP HOLDINGS INC | 18.19 | 22.88B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.13 | 20.24B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 126.14 | 16.54B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.11 | 14.50B | ||
| HIMS | HIMS & HERS HEALTH INC | 67.75 | 12.25B | ||
| DVA | DAVITA INC | 13.5 | 9.35B | ||
| GH | GUARDANT HEALTH INC | N/A | 6.79B | ||
| CHE | CHEMED CORP | 19.69 | 6.42B | ||
| RDNT | RADNET INC | 209.64 | 5.81B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.89 | 4.84B |
Related stock screener links
About CCEL
Company Profile
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 82 full-time employees. The firm operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The firm stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The firm markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Company Info
CRYO-CELL INTL INC
700 Brooker Creek Blvd, Suite 1800
Oldsmar FLORIDA US
CEO: David Portnoy
Employees: 84
Phone: 18137492104
CRYO-CELL INTL INC / CCEL FAQ
What is the stock price of CRYO-CELL INTL INC today?
The current stock price of CCEL is 4.4 USD. The price decreased by -2.65% in the last trading session.
What is the ticker symbol for CRYO-CELL INTL INC stock?
The exchange symbol of CRYO-CELL INTL INC is CCEL and it is listed on the NYSE Arca exchange.
On which exchange is CCEL stock listed?
CCEL stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for CRYO-CELL INTL INC stock?
7 analysts have analysed CCEL and the average price target is 8.67 USD. This implies a price increase of 97.05% is expected in the next year compared to the current price of 4.4. Check the CRYO-CELL INTL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CRYO-CELL INTL INC worth?
CRYO-CELL INTL INC (CCEL) has a market capitalization of 35.46M USD. This makes CCEL a Nano Cap stock.
How many employees does CRYO-CELL INTL INC have?
CRYO-CELL INTL INC (CCEL) currently has 84 employees.
What are the support and resistance levels for CRYO-CELL INTL INC (CCEL) stock?
CRYO-CELL INTL INC (CCEL) has a support level at 4.47 and a resistance level at 4.52. Check the full technical report for a detailed analysis of CCEL support and resistance levels.
Is CRYO-CELL INTL INC (CCEL) expected to grow?
The Revenue of CRYO-CELL INTL INC (CCEL) is expected to decline by -0.13% in the next year. Check the estimates tab for more information on the CCEL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CRYO-CELL INTL INC (CCEL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CCEL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CCEL, evaluating the profitability, health, valuation and growth aspects
- CRYO-CELL INTL INC (CCEL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CRYO-CELL INTL INC (CCEL) Sales and EPS estimates to see what analysts future expectations are.
- CRYO-CELL INTL INC (CCEL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CRYO-CELL INTL INC (CCEL) Insider and Institutional Ownership to learn about the owners and their transactions.
- CRYO-CELL INTL INC (CCEL) Stock Chart to make your own analysis
- CRYO-CELL INTL INC (CCEL) Latest news and press-releases to stay up to date.
Does CRYO-CELL INTL INC (CCEL) stock pay dividends?
CRYO-CELL INTL INC (CCEL) has a dividend yield of 18.57%. The yearly dividend amount is currently 0.25. Check the full fundamental report for a detailed analysis of CCEL dividend history, reliability and sustainability.
When does CRYO-CELL INTL INC (CCEL) report earnings?
CRYO-CELL INTL INC (CCEL) will report earnings on 2025-10-10, after the market close.
What is the Price/Earnings (PE) ratio of CRYO-CELL INTL INC (CCEL)?
CRYO-CELL INTL INC (CCEL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
What is the Short Interest ratio of CRYO-CELL INTL INC (CCEL) stock?
The outstanding short interest for CRYO-CELL INTL INC (CCEL) is 0.25% of its float. Check the ownership tab for more information on the CCEL short interest.
CCEL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CCEL. When comparing the yearly performance of all stocks, CCEL is a bad performer in the overall market: 89.87% of all stocks are doing better.
CCEL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CCEL. There are concerns on the financial health of CCEL while its profitability can be described as average.
CCEL Financial Highlights
Over the last trailing twelve months CCEL reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 98.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CCEL Forecast & Estimates
7 analysts have analysed CCEL and the average price target is 8.67 USD. This implies a price increase of 97.05% is expected in the next year compared to the current price of 4.4.
For the next year, analysts expect an EPS growth of -100% and a revenue growth -0.13% for CCEL